Recruiting Alzheimers Disease Studies in Palo Alto
About Alzheimers Disease Clinical Trials in Palo Alto
Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.
There are currently 33 alzheimers disease clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 21,183 participants. Research is being sponsored by Photocure, American Society of Clinical Oncology, Merck Sharp & Dohme LLC and 26 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alzheimers Disease Clinical Trials in Palo Alto — FAQ
Are there alzheimers disease clinical trials in Palo Alto?
Yes, there are 33 alzheimers disease clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What alzheimers disease treatments are being tested?
The 33 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.
Data updated July 18, 2026 from ClinicalTrials.gov